August 28, 2018

THERATECHNOLOGIES FILES MARKETING AUTHORIZATION APPLICATION FOR TROGARZOTM IN EUROPE

Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that the application for marketing authorization of TrogarzoTM (ibalizumab) was filed with the European Medicines Agency (“EMA”) through its centralized procedure.